Global Intravenous Immunoglobulins Market Report 2018 - Industry Analysis, Size, Share, production and Forecasts to 2025

 Buy Now

   Published Date : Aug-2018   |    Format : PDF   |    Pages : 95
This report studies the global market size of Intravenous Immunoglobulins in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intravenous Immunoglobulins in these regions.
This research report categorizes the global Intravenous Immunoglobulins market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Immunoglobulin therapy is the use of a mixture of antibodies (immunoglobulins) to treat a number of health conditions. These conditions include primary immunodeficiency, idiopathic thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy, Kawasaki disease, certain cases of HIV/AIDS and measles, Guillain-Barré syndrome, and in certain other infections when a more specific immunoglobulin is not available. Depending on the formulation it can be given by injection into muscle, a vein, or under the skin.
Intravenous formulations began to be approved in the 1980s, which represented a significant improvement over intramuscular objections, as they allowed for a sufficient amount of immunoglobulin to be injected to reach clinical efficacy, although they still had a fairly high rate of adverse effects.
In 2017, the global Intravenous Immunoglobulins market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Intravenous Immunoglobulins market based on company, product type, application and key regions.

The various contributors involved in the value chain of Intravenous Immunoglobulins include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Intravenous Immunoglobulins include
    CSL Behring
    Grifols
    Octapharma
    Shire
    ADMA Biologics
    Bayer
    Bharat Serum and Vaccines
    Biotest
    China Biologic Products
    Hualan Biological Engineering
    Kedrion Biopharma
    LFB Group
    Sanquin

Market Size Split by Type
    Neurology Intravenous Immunoglobulins
    Hematology Intravenous Immunoglobulins
    Immunology Intravenous Immunoglobulins
Market Size Split by Application
    Primary Immunodeficiency
    Idiopathic Thrombocytopenic Purpura
    Chronic Inflammatory Demyelinating Polyneuropathy
    Kawasaki Disease
    Guillain-Barre Syndrome

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Intravenous Immunoglobulins market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Intravenous Immunoglobulins market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Intravenous Immunoglobulins manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Intravenous Immunoglobulins with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Intravenous Immunoglobulins submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Intravenous Immunoglobulins are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intravenous Immunoglobulins market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Intravenous Immunoglobulins Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Intravenous Immunoglobulins Market Size Growth Rate by Type
        1.4.2 Neurology Intravenous Immunoglobulins
        1.4.3 Hematology Intravenous Immunoglobulins
        1.4.4 Immunology Intravenous Immunoglobulins
    1.5 Market by Application
        1.5.1 Global Intravenous Immunoglobulins Market Size Growth Rate by Application
        1.5.2 Primary Immunodeficiency
        1.5.3 Idiopathic Thrombocytopenic Purpura
        1.5.4 Chronic Inflammatory Demyelinating Polyneuropathy
        1.5.5 Kawasaki Disease
        1.5.6 Guillain-Barre Syndrome
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Intravenous Immunoglobulins Market Size
        2.1.1 Global Intravenous Immunoglobulins Revenue 2016-2025
        2.1.2 Global Intravenous Immunoglobulins Sales 2016-2025
    2.2 Intravenous Immunoglobulins Growth Rate by Regions
        2.2.1 Global Intravenous Immunoglobulins Sales by Regions
        2.2.2 Global Intravenous Immunoglobulins Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Intravenous Immunoglobulins Sales by Manufacturers
        3.1.1 Intravenous Immunoglobulins Sales by Manufacturers
        3.1.2 Intravenous Immunoglobulins Sales Market Share by Manufacturers
        3.1.3 Global Intravenous Immunoglobulins Market Concentration Ratio (CR5 and HHI)
    3.2 Intravenous Immunoglobulins Revenue by Manufacturers
        3.2.1 Intravenous Immunoglobulins Revenue by Manufacturers (2016-2018)
        3.2.2 Intravenous Immunoglobulins Revenue Share by Manufacturers (2016-2018)
    3.3 Intravenous Immunoglobulins Price by Manufacturers
    3.4 Intravenous Immunoglobulins Manufacturing Base Distribution, Product Types
        3.4.1 Intravenous Immunoglobulins Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Intravenous Immunoglobulins Product Category
        3.4.3 Date of International Manufacturers Enter into Intravenous Immunoglobulins  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Intravenous Immunoglobulins Sales by Type
    4.2 Global Intravenous Immunoglobulins Revenue by Type
    4.3 Intravenous Immunoglobulins Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Intravenous Immunoglobulins Breakdown Data by Application

6 North America
    6.1 North America Intravenous Immunoglobulins by Countries
        6.1.1 North America Intravenous Immunoglobulins Sales by Countries
        6.1.2 North America Intravenous Immunoglobulins Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Intravenous Immunoglobulins by Type
    6.3 North America Intravenous Immunoglobulins by Application
    6.4 North America Intravenous Immunoglobulins by Company

7 Europe
    7.1 Europe Intravenous Immunoglobulins by Countries
        7.1.1 Europe Intravenous Immunoglobulins Sales by Countries
        7.1.2 Europe Intravenous Immunoglobulins Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Intravenous Immunoglobulins by Type
    7.3 Europe Intravenous Immunoglobulins by Application
    7.4 Europe Intravenous Immunoglobulins by Company

8 Asia Pacific
    8.1 Asia Pacific Intravenous Immunoglobulins by Countries
        8.1.1 Asia Pacific Intravenous Immunoglobulins Sales by Countries
        8.1.2 Asia Pacific Intravenous Immunoglobulins Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Intravenous Immunoglobulins by Type
    8.3 Asia Pacific Intravenous Immunoglobulins by Application
    8.4 Asia Pacific Intravenous Immunoglobulins by Company

9 Central & South America
    9.1 Central & South America Intravenous Immunoglobulins by Countries
        9.1.1 Central & South America Intravenous Immunoglobulins Sales by Countries
        9.1.2 Central & South America Intravenous Immunoglobulins Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Intravenous Immunoglobulins by Type
    9.3 Central & South America Intravenous Immunoglobulins by Application
    9.4 Central & South America Intravenous Immunoglobulins by Company

10 Middle East and Africa
    10.1 Middle East and Africa Intravenous Immunoglobulins by Countries
        10.1.1 Middle East and Africa Intravenous Immunoglobulins Sales by Countries
        10.1.2 Middle East and Africa Intravenous Immunoglobulins Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Intravenous Immunoglobulins by Type
    10.3 Middle East and Africa Intravenous Immunoglobulins by Application
    10.4 Middle East and Africa Intravenous Immunoglobulins by Company

11 Company Profiles
    11.1 CSL Behring
        11.1.1 CSL Behring Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Intravenous Immunoglobulins
        11.1.4 Intravenous Immunoglobulins Product Description
        11.1.5 Recent Development
    11.2 Grifols
        11.2.1 Grifols Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Intravenous Immunoglobulins
        11.2.4 Intravenous Immunoglobulins Product Description
        11.2.5 Recent Development
    11.3 Octapharma
        11.3.1 Octapharma Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Intravenous Immunoglobulins
        11.3.4 Intravenous Immunoglobulins Product Description
        11.3.5 Recent Development
    11.4 Shire
        11.4.1 Shire Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Intravenous Immunoglobulins
        11.4.4 Intravenous Immunoglobulins Product Description
        11.4.5 Recent Development
    11.5 ADMA Biologics
        11.5.1 ADMA Biologics Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Intravenous Immunoglobulins
        11.5.4 Intravenous Immunoglobulins Product Description
        11.5.5 Recent Development
    11.6 Bayer
        11.6.1 Bayer Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Intravenous Immunoglobulins
        11.6.4 Intravenous Immunoglobulins Product Description
        11.6.5 Recent Development
    11.7 Bharat Serum and Vaccines
        11.7.1 Bharat Serum and Vaccines Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of Intravenous Immunoglobulins
        11.7.4 Intravenous Immunoglobulins Product Description
        11.7.5 Recent Development
    11.8 Biotest
        11.8.1 Biotest Company Details
        11.8.2 Company Description
        11.8.3 Sales, Revenue and Gross Margin of Intravenous Immunoglobulins
        11.8.4 Intravenous Immunoglobulins Product Description
        11.8.5 Recent Development
    11.9 China Biologic Products
        11.9.1 China Biologic Products Company Details
        11.9.2 Company Description
        11.9.3 Sales, Revenue and Gross Margin of Intravenous Immunoglobulins
        11.9.4 Intravenous Immunoglobulins Product Description
        11.9.5 Recent Development
    11.10 Hualan Biological Engineering
        11.10.1 Hualan Biological Engineering Company Details
        11.10.2 Company Description
        11.10.3 Sales, Revenue and Gross Margin of Intravenous Immunoglobulins
        11.10.4 Intravenous Immunoglobulins Product Description
        11.10.5 Recent Development
    11.11 Kedrion Biopharma
    11.12 LFB Group
    11.13 Sanquin

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Intravenous Immunoglobulins Raw Material
        13.1.2 Intravenous Immunoglobulins Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Intravenous Immunoglobulins
    Figure Global Intravenous Immunoglobulins Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Intravenous Immunoglobulins Production Market Share by Types (Product Category) in 2017
    Figure Neurology Intravenous Immunoglobulins Product Picture
    Table Major Manufacturers of Neurology Intravenous Immunoglobulins
    Figure Hematology Intravenous Immunoglobulins Product Picture
    Table Major Manufacturers of Hematology Intravenous Immunoglobulins
    Figure Immunology Intravenous Immunoglobulins Product Picture
    Table Major Manufacturers of Immunology Intravenous Immunoglobulins
    Table Global Intravenous Immunoglobulins Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure Primary Immunodeficiency
    Figure Idiopathic Thrombocytopenic Purpura
    Figure Chronic Inflammatory Demyelinating Polyneuropathy
    Figure Kawasaki Disease
    Figure Guillain-Barre Syndrome
    Figure Intravenous Immunoglobulins Report Years Considered
    Figure Global Intravenous Immunoglobulins Market Size 2016-2025 (Million US$)
    Figure Global Intravenous Immunoglobulins Sales 2016-2025 (K Units)
    Table Global Intravenous Immunoglobulins Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global Intravenous Immunoglobulins Sales by Regions 2016-2025 (K Units)
    Table Global Intravenous Immunoglobulins Sales Market Share by Regions 2016-2025
    Figure Global Intravenous Immunoglobulins Sales Market Share by Regions 2016-2025
    Figure 2017 Global Intravenous Immunoglobulins Sales Market Share by Regions
    Table Global Intravenous Immunoglobulins Revenue by Regions 2016-2025 (Million US$)
    Table Global Intravenous Immunoglobulins Revenue Market Share by Regions 2016-2025
    Figure Global Intravenous Immunoglobulins Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Intravenous Immunoglobulins Revenue Market Share by Regions
    Table Global Intravenous Immunoglobulins Sales by Manufacturers (2016-2018) (K Units)
    Table Global Intravenous Immunoglobulins Sales Share by Manufacturers (2016-2018)
    Figure Global Intravenous Immunoglobulins Sales Share by Manufacturers in 2017
    Table Intravenous Immunoglobulins Revenue by Manufacturers (2016-2018) (Million US$)
    Table Intravenous Immunoglobulins Revenue Share by Manufacturers (2016-2018)
    Figure Intravenous Immunoglobulins Value Share by Manufacturers in 2017
    Table Global Intravenous Immunoglobulins Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Intravenous Immunoglobulins Price (2016-2018) (USD/Unit)
    Table Intravenous Immunoglobulins Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Intravenous Immunoglobulins Product Category
    Table Date of International Manufacturers Enter into Intravenous Immunoglobulins Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Intravenous Immunoglobulins Sales by Type (2016-2025) (K Units)
    Table Global Intravenous Immunoglobulins Sales Share by Type (2016-2025)
    Figure Global Intravenous Immunoglobulins Sales Market Share by Type (2016-2025)
    Figure Global Intravenous Immunoglobulins Sales Market Share by Type in 2017
    Table Global Intravenous Immunoglobulins Revenue by Type (2016-2025) (Million US$)
    Table Global Intravenous Immunoglobulins Revenue Share by Type (2016-2025)
    Figure Global Intravenous Immunoglobulins Revenue Market Share by Type (2016-2025)
    Figure Global Intravenous Immunoglobulins Revenue Market Share by Type in 2017
    Table Intravenous Immunoglobulins Price by Type 2013-2018 (USD/Unit)
    Table Global Intravenous Immunoglobulins Sales by Application (2016-2025) (K Units)
    Table Global Intravenous Immunoglobulins Sales Share by Application (2016-2025)
    Figure Global Sales Intravenous Immunoglobulins Market Share by Application (2016-2025)
    Figure Global Sales Intravenous Immunoglobulins Market Share by Application (2016-2025)
    Figure North America Intravenous Immunoglobulins Sales Growth Rate 2016-2025 (K Units)
    Figure North America Intravenous Immunoglobulins Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Intravenous Immunoglobulins Sales by Countries (2016-2025) (K Units)
    Table North America Intravenous Immunoglobulins Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Intravenous Immunoglobulins Sales Market Share by Countries
    Table North America Intravenous Immunoglobulins Revenue by Countries (2016-2025) (Million US$)
    Table North America Intravenous Immunoglobulins Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Intravenous Immunoglobulins Revenue Market Share by Countries
    Figure United States Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure United States Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Canada Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Intravenous Immunoglobulins Sales by Type (2016-2025) (K Units)
    Table North America Intravenous Immunoglobulins Sales Market Share by Type (2016-2025)
    Figure 2017 North America Intravenous Immunoglobulins Market Share by Type
    Table North America Intravenous Immunoglobulins Sales by Application (2016-2025) (K Units)
    Table North America Intravenous Immunoglobulins Sales Market Share by Application (2016-2025)
    Figure 2017 North America Intravenous Immunoglobulins Market Share by Application
    Table North America Intravenous Immunoglobulins Sales by Company (2016-2018) (K Units)
    Table North America Intravenous Immunoglobulins Sales Market Share by Company (2016-2018)
    Figure North America Intravenous Immunoglobulins Sales Market Share by Company in 2017
    Figure Europe Intravenous Immunoglobulins Sales Growth Rate 2016-2025 (K Units)
    Figure Europe Intravenous Immunoglobulins Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Intravenous Immunoglobulins Sales by Countries (2016-2025) (K Units)
    Table Europe Intravenous Immunoglobulins Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Intravenous Immunoglobulins Sales Market Share by Countries
    Table Europe Intravenous Immunoglobulins Revenue by Countries (2016-2025) (Million US$)
    Table Europe Intravenous Immunoglobulins Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Intravenous Immunoglobulins Revenue Market Share by Countries
    Figure Germany Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Germany Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (K Units)
    Figure France Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure France Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (K Units)
    Figure UK Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure UK Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Italy Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Russia Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Intravenous Immunoglobulins Sales by Type (2016-2025) (K Units)
    Table Europe Intravenous Immunoglobulins Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Intravenous Immunoglobulins Market Share by Type
    Table Europe Intravenous Immunoglobulins Sales by Application (2016-2025) (K Units)
    Table Europe Intravenous Immunoglobulins Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Intravenous Immunoglobulins Market Share by Application
    Table Europe Intravenous Immunoglobulins Sales by Company (2016-2018) (K Units)
    Table Europe Intravenous Immunoglobulins Sales Market Share by Company (2016-2018)
    Figure Europe Intravenous Immunoglobulins Sales Market Share by Company in 2017
    Figure Asia Pacific Intravenous Immunoglobulins Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific Intravenous Immunoglobulins Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Intravenous Immunoglobulins Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific Intravenous Immunoglobulins Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Intravenous Immunoglobulins Sales Market Share by Countries
    Table Asia Pacific Intravenous Immunoglobulins Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Intravenous Immunoglobulins Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Intravenous Immunoglobulins Revenue Market Share by Countries
    Figure China Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure China Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Japan Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Korea Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure India Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Australia Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Intravenous Immunoglobulins Sales by Type (2016-2025) (K Units)
    Table Asia Pacific Intravenous Immunoglobulins Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Intravenous Immunoglobulins Market Share by Type
    Table Asia Pacific Intravenous Immunoglobulins Sales by Application (2016-2025) (K Units)
    Table Asia Pacific Intravenous Immunoglobulins Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Intravenous Immunoglobulins Market Share by Application
    Table Asia Pacific Intravenous Immunoglobulins Sales by Company (2016-2018) (K Units)
    Table Asia Pacific Intravenous Immunoglobulins Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Intravenous Immunoglobulins Sales Market Share by Company in 2017
    Figure Central & South America Intravenous Immunoglobulins Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America Intravenous Immunoglobulins Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Intravenous Immunoglobulins Sales by Countries (2016-2025) (K Units)
    Table Central & South America Intravenous Immunoglobulins Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Intravenous Immunoglobulins Sales Market Share by Countries
    Table Central & South America Intravenous Immunoglobulins Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Intravenous Immunoglobulins Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Intravenous Immunoglobulins Revenue Market Share by Countries
    Figure Brazil Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Intravenous Immunoglobulins Sales by Type (2016-2025) (K Units)
    Table Central & South America Intravenous Immunoglobulins Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Intravenous Immunoglobulins Market Share by Type
    Table Central & South America Intravenous Immunoglobulins Sales by Application (2016-2025) (K Units)
    Table Central & South America Intravenous Immunoglobulins Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Intravenous Immunoglobulins Market Share by Application
    Table Central & South America Intravenous Immunoglobulins Sales by Company (2016-2018) (K Units)
    Table Central & South America Intravenous Immunoglobulins Sales Market Share by Company (2016-2018)
    Figure Central & South America Intravenous Immunoglobulins Sales Market Share by Company in 2017
    Figure Middle East and Africa Intravenous Immunoglobulins Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa Intravenous Immunoglobulins Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Intravenous Immunoglobulins Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa Intravenous Immunoglobulins Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Intravenous Immunoglobulins Sales Market Share by Countries
    Table Middle East and Africa Intravenous Immunoglobulins Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Intravenous Immunoglobulins Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Intravenous Immunoglobulins Revenue Market Share by Countries
    Figure GCC Countries Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Intravenous Immunoglobulins Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa Intravenous Immunoglobulins Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Intravenous Immunoglobulins Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa Intravenous Immunoglobulins Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Intravenous Immunoglobulins Market Share by Type
    Table Middle East and Africa Intravenous Immunoglobulins Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa Intravenous Immunoglobulins Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Intravenous Immunoglobulins Market Share by Application
    Table Middle East and Africa Intravenous Immunoglobulins Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa Intravenous Immunoglobulins Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Intravenous Immunoglobulins Sales Market Share by Company in 2017
    Table CSL Behring Company Details
    Table CSL Behring Intravenous Immunoglobulins Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table CSL Behring Recent Development
    Table Grifols Company Details
    Table Grifols Intravenous Immunoglobulins Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Grifols Recent Development
    Table Octapharma Company Details
    Table Octapharma Intravenous Immunoglobulins Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Octapharma Recent Development
    Table Shire Company Details
    Table Shire Intravenous Immunoglobulins Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Shire Recent Development
    Table ADMA Biologics Company Details
    Table ADMA Biologics Intravenous Immunoglobulins Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table ADMA Biologics Recent Development
    Table Bayer Company Details
    Table Bayer Intravenous Immunoglobulins Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Bayer Recent Development
    Table Bharat Serum and Vaccines Company Details
    Table Bharat Serum and Vaccines Intravenous Immunoglobulins Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Bharat Serum and Vaccines Recent Development
    Table Biotest Company Details
    Table Biotest Intravenous Immunoglobulins Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Biotest Recent Development
    Table China Biologic Products Company Details
    Table China Biologic Products Intravenous Immunoglobulins Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table China Biologic Products Recent Development
    Table Hualan Biological Engineering Company Details
    Table Hualan Biological Engineering Intravenous Immunoglobulins Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Hualan Biological Engineering Recent Development
    Table Kedrion Biopharma Company Details
    Table LFB Group Company Details
    Table Sanquin Company Details
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Intravenous Immunoglobulins Value Chain
    Table Typical Suppliers of Key Intravenous Immunoglobulins Raw Material
    Table Intravenous Immunoglobulins Customers List
    Table Intravenous Immunoglobulins Sales Channels
    Table Intravenous Immunoglobulins Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

25-Feb-2019 | Chemicals & Materials

Industrial Alliance To Help Waste Management Market To Rise

An alliance of 28 large companies has launched a global organization to find solutions to remove plastic waste from the environment. The Alliance for the Disposal of Plastic Waste (AEPW), which collaborates with the World Business Council for Sustainable Development (WBCSD), brings together chemical and plastic companies as well as consumer goods companies.

25-Feb-2019 | Electrical & Electronic Device

Insights Into Fish’s Swimming Adds Sensory Feedback Feature To Global Robotics Market

The fish have a random movement with excellent sensory feedback so as to help them navigate the world. According to the Johns Hopkins University researchers, the inclusion of this movement in understanding the active sensing behaviors of animals can actually help advance the robotic platform in terms of medical, industrial, defense, and commercial sectors. The sensors can help improve the inter ...

13-Feb-2019 | Technology

Battle Between Apple And Qualcomm Likely To Impact The Growth Of The Smartphone Market

The smartphone market has observed a tremendous transformation owing to advancement in technology, better services, the advent of 4G & 5G networks, and so on. Recently, Qualcomm Inc had filed a patent lawsuit against Apple Inc that imposed a veto on sales of few iPhone devices in Germany. This, certainly, was expected to pose a negative impact on the growth of the smartphone market in that ...

13-Feb-2019 | Food & Beverage

Belizean Turmeric Gets Place in Global Turmeric Market

A novel product manufactured from Belizean-grown turmeric has started to hit the shelves of grocery stores in Belize as well as in Canada. The latest product is supposed to catch the turmeric market in the rest of the Caribbean as well. This budge is supposed to offer novel opportunities to farmers as well as agro-processors in the Toledo district. Till date, more than 350 turmeric cultivators ...

05-Feb-2019 | Automobile

Automotive Mobility Market Growth Has A Handle On New AEye Product Sale

The automotive mobility market will be skyrocketing by this year as AEye, which is one of the world’s best artificial perception systems and the maker of iDAR has recently declared that it will be launching the AE110. The new technology has been built on the highly wide-ranging solid-state LiDAR patent portfolio. The AE110 is the only one possessing the firm's solitary software-linked ...